Hepatocellular Adenoma

Hepatocellular adenoma (also known as hepatic adenoma or hepadenoma) is a rare, benign liver tumor. It most commonly occurs in people with elevated systemic levels of estrogen, classically in women taking estrogen-containing oral contraceptive medication. Hepatic adenoma is usually detected by imaging, typically an ultrasound or CT, as a hyper enhancing liver nodule. Given that several liver tumors appear similarly on these imaging modalities, a multi-phase contrast-enhanced imaging study such as CT or MRI may be used to provide more information.

You may not know you have a hepatic adenoma unless it ruptures. A ruptured hepatic adenoma is serious. It can cause:


  • sudden abdominal pain low blood pressure internal bleeding
  • low blood pressure
  • internal bleeding

Related Conference of Hepatocellular Adenoma

February 21-22, 2022

17th Euro-Global Gastroenterology Conference

Berlin, Germany
April 25-26, 2022

International Conference on Hepatitis & Liver diseases

Sydney, Australia
May 12-13, 2022

Summit on Pancreas, Gastroenterology and Digestive Diseases

Amsterdam, Netherlands
June 13-14, 2022

28th World Conference on Gastroenterology & Hepatology

Amsterdam, Netherlands
July 18-19, 2022

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
July 20-21, 2022

21th World Gastroenterologists Summit

Osaka, Japan
July 20-21, 2022

Digestive disorders 2022

Amsterdam, Netherlands
August 03-04, 2022

31st World Congress on Nursing

Rome, Italy
November 14-15, 2022

13th International Conference on Liver Diseases & Hepatology

Amsterdam, Netherlands

Hepatocellular Adenoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in